U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07013773) titled 'To Evaluate the Effect of Food on the Pharmacokinetics of Y-4 Tablets in Healthy Subjects' on May 27.
Brief Summary: Y-4 is a new fixed-dose combination drug product containing two active ingredients of pregabalin and riluzole.
The objective is to assess the effect of food on the pharmacokinetics (PK) of pregabalin and riluzole in healthy adult subjects after a single oral dose of Y-4 tablets.
Study Start Date: May 19
Study Type: INTERVENTIONAL
Condition:
Healthy Male and Female Subjects
Intervention:
DRUG: Y-4 tablet
The enrolled subjects will be randomly divided into group AB and group BA, with a total of 10 subjects in ea...